207 related articles for article (PubMed ID: 33568778)
1. FBXL6 degrades phosphorylated p53 to promote tumor growth.
Li Y; Cui K; Zhang Q; Li X; Lin X; Tang Y; Prochownik EV; Li Y
Cell Death Differ; 2021 Jul; 28(7):2112-2125. PubMed ID: 33568778
[TBL] [Abstract][Full Text] [Related]
2. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
Cell Commun Signal; 2020 Jun; 18(1):100. PubMed ID: 32576198
[TBL] [Abstract][Full Text] [Related]
3. FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15.
Li N; Lorenzi F; Kalakouti E; Normatova M; Babaei-Jadidi R; Tomlinson I; Nateri AS
Oncotarget; 2015 Apr; 6(11):9240-56. PubMed ID: 25860929
[TBL] [Abstract][Full Text] [Related]
4. Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation.
Neitzel C; Seiwert N; Göder A; Diehl E; Weber C; Nagel G; Stroh S; Rasenberger B; Christmann M; Fahrer J
Cells; 2019 Jul; 8(8):. PubMed ID: 31366086
[TBL] [Abstract][Full Text] [Related]
5. TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity.
Chen D; Ming L; Zou F; Peng Y; Van Houten B; Yu J; Zhang L
Oncotarget; 2014 Sep; 5(18):8107-22. PubMed ID: 25237903
[TBL] [Abstract][Full Text] [Related]
6. FBXL20-mediated Vps34 ubiquitination as a p53 controlled checkpoint in regulating autophagy and receptor degradation.
Xiao J; Zhang T; Xu D; Wang H; Cai Y; Jin T; Liu M; Jin M; Wu K; Yuan J
Genes Dev; 2015 Jan; 29(2):184-96. PubMed ID: 25593308
[TBL] [Abstract][Full Text] [Related]
7. MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance.
Zhou S; Lu J; Li Y; Chen C; Cai Y; Tan G; Peng Z; Zhang Z; Dong Z; Kang T; Tang F
J Exp Clin Cancer Res; 2018 Nov; 37(1):284. PubMed ID: 30477538
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide reactivates proteasome-dependent degradation of mutant p53 protein in cancer cells in part via enhanced expression of Pirh2 E3 ligase.
Yan W; Jung YS; Zhang Y; Chen X
PLoS One; 2014; 9(8):e103497. PubMed ID: 25116336
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA PiHL regulates p53 protein stability through GRWD1/RPL11/MDM2 axis in colorectal cancer.
Deng X; Li S; Kong F; Ruan H; Xu X; Zhang X; Wu Z; Zhang L; Xu Y; Yuan H; Peng H; Yang D; Guan M
Theranostics; 2020; 10(1):265-280. PubMed ID: 31903119
[TBL] [Abstract][Full Text] [Related]
10. Fbw7 and p53 cooperatively suppress advanced and chromosomally unstable intestinal cancer.
Grim JE; Knoblaugh SE; Guthrie KA; Hagar A; Swanger J; Hespelt J; Delrow JJ; Small T; Grady WM; Nakayama KI; Clurman BE
Mol Cell Biol; 2012 Jun; 32(11):2160-7. PubMed ID: 22473991
[TBL] [Abstract][Full Text] [Related]
11. SNX16 activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of eEF1A2 in colorectal cancer development.
Shen Z; Li Y; Fang Y; Lin M; Feng X; Li Z; Zhan Y; Liu Y; Mou T; Lan X; Wang Y; Li G; Wang J; Deng H
Mol Oncol; 2020 Feb; 14(2):387-406. PubMed ID: 31876369
[TBL] [Abstract][Full Text] [Related]
12. FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53.
Xu M; Zhu J; Liu S; Wang C; Shi Q; Kuang Y; Fang X; Hu X
Carcinogenesis; 2020 Sep; 41(9):1253-1262. PubMed ID: 31784734
[TBL] [Abstract][Full Text] [Related]
13. The p53-inducible CLDN7 regulates colorectal tumorigenesis and has prognostic significance.
Hou Y; Hou L; Liang Y; Zhang Q; Hong X; Wang Y; Huang X; Zhong T; Pang W; Xu C; Zhu L; Li L; Fang J; Meng X
Neoplasia; 2020 Nov; 22(11):590-603. PubMed ID: 32992138
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
[TBL] [Abstract][Full Text] [Related]
15. NIR promotes progression of colorectal cancer through regulating RB.
Li Y; Wang L; Liu X; Zhang C; Du X; Xing B
Biochim Biophys Acta Mol Cell Res; 2021 Jan; 1868(1):118856. PubMed ID: 32931817
[TBL] [Abstract][Full Text] [Related]
16. FIT links c-Myc and P53 acetylation by recruiting RBBP7 during colorectal carcinogenesis.
Guo L; Xia Y; Li H; Wang Z; Xu H; Dai X; Zhang Y; Zhang H; Fan W; Wei F; Li Q; Zhang L; Cao L; Zhang S; Hu W; Gu H
Cancer Gene Ther; 2023 Aug; 30(8):1124-1133. PubMed ID: 37225855
[TBL] [Abstract][Full Text] [Related]
17. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S
Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406
[TBL] [Abstract][Full Text] [Related]
18. MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance.
Lu J; Li Y; Wu Y; Zhou S; Duan C; Dong Z; Kang T; Tang F
Theranostics; 2018; 8(19):5289-5306. PubMed ID: 30555547
[TBL] [Abstract][Full Text] [Related]
19. FBXO16-mediated hnRNPL ubiquitination and degradation plays a tumor suppressor role in ovarian cancer.
Ji M; Zhao Z; Li Y; Xu P; Shi J; Li Z; Wang K; Huang X; Ji J; Liu W; Liu B
Cell Death Dis; 2021 Jul; 12(8):758. PubMed ID: 34333526
[TBL] [Abstract][Full Text] [Related]
20. Ras association domain family 1 isoform A suppresses colonic tumor cell growth through p21
Oh SJ; Lee MG; Moon JR; Lee CK; Chi SG; Kim HJ
J Gastroenterol Hepatol; 2019 May; 34(5):890-898. PubMed ID: 30226276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
